Michael Szardenings
Cell Therapy and Immunology
Fraunhofer Institute for Chemical Technology
Germany
Biography
Michael Szardenings has a great personal interest in the advancement of combinatorial methods at the border line between Molecular Biology, Medicine and Chemistry and its exploration for pharmaceutical and medical relevant research. He has been working with enzyme inhibitors as well as membrane and nuclear receptors. His present research activities focus on the improvement of peptide phage display methods to establish novel cell type specific ligands and towards a better understanding of the immune response amongst others in allergies and infectious diseases. He studied Chemistry from Hamburg University with a Diploma Thesis on bioluminescent nucleic acid derivatives in 1985. Three years later, he received a Doctoral degree at the former German Biotechnology Center GBF (Braunschweig) for protein design of protease inhibitor hPSTI. After Post-doctoral years in protein crystallography and research on melanocortin receptors, he served as CSO and CBO for phage display and CRO companies between 1998 and 2009, when he was appointed as Group Leader of a continuously growing group at Fraunhofer IZI in Leipzig. He is now also heading a spin-off company in Leipzig for epitope mapping services.
Research Interest
Molecular Biology
